Is Jyothy Labs overvalued or undervalued?

As of 31 October 2025, the valuation grade for Jyothy Labs has moved from attractive to very attractive. The company is currently assessed as undervalued. Key ratios include a PE Ratio of 30.94, an EV to EBITDA of 22.05, and a ROCE of 29.33%.
In comparison to its peers, Jyothy Labs stands out with a significantly lower PE Ratio than Hindustan Unilever at 54.79 and Nestle India at 81.91, both categorized as very expensive. Despite recent stock performance showing a decline of 39.89% over the past year compared to a 5.73% increase in the Sensex, the strong financial metrics suggest that Jyothy Labs presents a compelling investment opportunity in the FMCG sector.